Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Quantitative CT of the orbit in Graves' disease.

Ozgen A, Alp MN, Ariyürek M, Tütüncü NB, Can I, Günalp I.

Br J Radiol. 1999 Aug;72(860):757-62.

PMID:
10624341
2.

Computed tomography in Graves' ophthalmopathy.

Enzmann D, Marshal WH Jr, Rosenthal AR, Kriss JP.

Radiology. 1976 Mar;118(3):615-20.

PMID:
946330
3.

Correlation of CT scanning and pathologic features of ophthalmic Graves' disease.

Trokel SL, Jakobiec FA.

Ophthalmology. 1981 Jun;88(6):553-64.

PMID:
6894976
4.
5.

Graves orbitopathy: correlation of CT and clinical findings.

Nugent RA, Belkin RI, Neigel JM, Rootman J, Robertson WD, Spinelli J, Graeb DA.

Radiology. 1990 Dec;177(3):675-82.

PMID:
2243967
6.

[Sonography of the retrobulbar space in autoimmune hyperthyroidism of the Basedow type].

Schillings S, Wagner J, Franzen W, Wildmeister W.

Z Gesamte Inn Med. 1990 Nov 15;45(22):678-83. German.

PMID:
2099028
7.

The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography.

Given-Wilson R, Pope RM, Michell MJ, Cannon R, McGregor AM.

Br J Radiol. 1989 Aug;62(740):705-9.

PMID:
2670033
8.

Quantitative evaluation of extraocular muscle with high-field magnetic resonance in patients with Graves' ophthalmopathy with upper-lid retraction.

Chen Y, Jin ZY, Zhang ZH, Xu DD, Meng W, Jiang B, Fang HY, Sun ZY, Chen Y, Sun HY, Feng F.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Oct;34(5):461-7. doi: 10.3881/j.issn.1000-503X.2012.05.005.

9.

Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle.

Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest F 4th.

AJNR Am J Neuroradiol. 1986 Jul-Aug;7(4):651-6.

PMID:
3088943
10.

[CT of the orbit in Graves' ophthalmopathy].

Bagnolesi P, Cilotti A, Bartalena L, Marcocci C, Pinchera A, Lepri A.

Radiol Med. 1990 Apr;79(4):302-7. Italian.

PMID:
2377747
11.
12.

Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease.

Chang TC, Huang KM, Chang TJ, Lin SL.

Clin Endocrinol (Oxf). 1990 May;32(5):551-8.

PMID:
2194711
13.

Serum levels of soluble Fas in patients with Graves' ophthalmopathy.

Ohtsuka K, Hashimoto M.

Br J Ophthalmol. 2000 Jan;84(1):103-6.

14.
15.

[MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].

Pauleit D, Schüller H, Textor J, Leutner C, Keller E, Sommer T, Träber F, Block W, Boldt I, Schild H.

Rofo. 1997 Dec;167(6):557-64. German.

PMID:
9465949
16.

A comparison of computed tomographic techniques in the diagnosis of Graves' ophthalmopathy.

Hunsaker JN, Anderson RE, Van Dyk HJ, Wing SD.

Ophthalmic Surg. 1979 Nov;10(11):34-40.

PMID:
583295
17.

Normative measurements of orbital structures using CT.

Ozgen A, Ariyurek M.

AJR Am J Roentgenol. 1998 Apr;170(4):1093-6.

PMID:
9530066
18.

Graves' ophthalmopathy: I. Simple CT estimates of extraocular muscle volume.

Hallin ES, Feldon SE.

Br J Ophthalmol. 1988 Sep;72(9):674-7.

19.

Appearance of Graves' disease on orbital computed tomography.

Enzmann DR, Donaldson SS, Kriss JP.

J Comput Assist Tomogr. 1979 Dec;3(6):815-9.

PMID:
583152
20.

Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.

Nishikawa M, Yoshimura M, Toyoda N, Masaki H, Yonemoto T, Gondou A, Kato T, Kurokawa H, Furumura T, Inada M.

Acta Endocrinol (Copenh). 1993 Sep;129(3):213-9.

PMID:
8105634

Supplemental Content

Support Center